Lymphatic Interventions · IR Playbook

Thoracic Duct Embolization and Disruption (TDE/TDD)

Thoracic duct embolization (TDE) is percutaneous image-guided occlusion of the thoracic duct or a causative lymphatic channel, usually with microcoils and n-butyl cyanoacrylate, for a persistent chylous leak. Thoracic duct disruption (TDD) is a salvage technique in which the cisterna chyli or major retroperitoneal lymphatic channels are repeatedly punctured when catheterization is unsuccessful. Intranodal lymphangiography and leak localization are prerequisite mapping steps and are covered only briefly here. Outcomes are generally better for traumatic or postoperative leaks than for nontraumatic lymphatic flow disorders.

Learning objectives

• Distinguish TDE from TDD and state when disruption is used
• Plan safe antegrade transabdominal access to the cisterna chyli or a lumbar lymphatic channel
• Perform ductography and embolize the correct segment without venous glue migration
• Recognize that lymphangiographic pattern and leak etiology influence clinical success
• Monitor drain response and detect access-related, embolic and delayed lymphatic complications

Indications

• Persistent postoperative or traumatic chylothorax despite appropriate drainage and nutritional or medical therapy
• Persistent cervical chyle leak after neck surgery when conservative measures are inadequate
• Recurrent or clinically significant chylous pleural, mediastinal or pericardial leak with a treatable central lymphatic abnormality
• Persistent leak after surgical thoracic duct ligation when lymphangiography demonstrates a residual duct, missed branch or collateral pathway
• Selected nontraumatic chylous effusion when dynamic or conventional lymphatic imaging demonstrates a leak, abnormal reflux or obstruction amenable to intervention
• TDD when the central lymphatics are opacified but thoracic duct catheterization for TDE fails

Relative contraindications

• Uncorrectable coagulopathy or severe thrombocytopenia
• No safe percutaneous access path to the central lymphatic target
• Uncontrolled infection or severe hemodynamic or respiratory instability
• Pregnancy because of fluoroscopy and oil-based contrast exposure unless benefit clearly outweighs risk
• Severe iodinated-contrast hypersensitivity requiring an alternative imaging and contrast strategy
• Nontraumatic diffuse lymphatic disease without a targetable leak or reflux pathway

Equipment

• High-frequency linear ultrasound transducer, sterile cover and 25–26 G needles for brief intranodal lymphangiographic mapping
• Ethiodized oil for intranodal lymphangiography and water-soluble iodinated contrast for ductography
• 15–20 cm 21 G Chiba or trocar needle for transabdominal central lymphatic access
• 0.018-inch hydrophilic or supportive microwire with steerable angled tip
• 2.4–3 Fr microcatheter compatible with the selected 0.018-inch wire
• 2–5 mm pushable or detachable microcoils selected to anchor within the duct
• NBCA and ethiodized oil, commonly prepared in a 1:1 ratio for central duct embolization
• 5% dextrose for catheter flushing during NBCA delivery, glue-compatible syringes and three-way stopcock
• Fluoroscopy with ultrasound; cone-beam CT or CT guidance when the target or trajectory is uncertain

Procedure steps

1. Review or briefly complete intranodal lymphangiography to identify the cisterna chyli, thoracic duct, leak, obstruction and collateral channels. Avoid repeating a full localization work-up when adequate recent mapping is already available.Pearl: A visible leak is not the only actionable pattern; duct obstruction with abnormal collateral flow may explain persistent chylous effusion.
2. Place the patient supine and select the most direct stable path to an opacified cisterna chyli or lumbar lymphatic channel. Use orthogonal fluoroscopy, cone-beam CT or CT when depth and intervening structures are uncertain.
3. Advance a long 21 G needle under image guidance to traverse the opacified central lymphatic target. After crossing the channel, withdraw slowly while gently probing with the 0.018-inch wire until the wire enters and advances cranially within the duct.Pearl: Intentional through-and-through puncture followed by wire probing during withdrawal is often more reliable than trying to stop exactly within the tiny duct.
4. Advance a 2.4–3 Fr microcatheter over the wire into the thoracic duct and position it as close as safely possible to the leak or abnormal channel. Confirm an intraluminal course in two projections before removing the wire.
5. Inject small controlled aliquots of water-soluble iodinated contrast through the microcatheter to define duct anatomy, extravasation, obstruction, reflux and the venous termination. Reassess whether global duct occlusion or a more selective intervention matches the demonstrated pathophysiology.
6. Place one or more appropriately oversized microcoils in the target duct upstream and caudal to the leak, leaving room for glue delivery. The coil mass slows flow, anchors the liquid embolic and limits cranial migration.
7. Flush the catheter with 5% dextrose, prepare NBCA with ethiodized oil, commonly 1:1, and inject under continuous fluoroscopy while withdrawing the catheter to cast the target duct and relevant tributaries. Stop immediately if glue approaches the venous angle or enters a non-target channel.Pearl: A relatively concentrated mixture polymerizes rapidly and helps limit cephalad migration in the central duct; adjust only for flow, catheter position and operator experience.
8. If the central lymphatics are opacified but cannot be catheterized, repeatedly puncture and macerate the cisterna chyli and major retroperitoneal lymphatic channels with the access needle. TDD is a salvage maneuver, not equivalent to a controlled intraluminal embolization.Pearl: Contrast extravasation and interruption of channel continuity confirm mechanical disruption.
9. Record the final coil and glue cast, treated duct level, leak relationship, any disrupted channels and absence of non-target venous embolization. Remove the needle and apply local compression and a sterile dressing.

Complications

• Access-site pain, bruising or small hematoma
• Retroperitoneal or intra-abdominal hemorrhage
• Visceral injury, pancreatitis, bile leak or peritonitis
• Non-target coil or glue embolization
• Persistent or recurrent chylous leak
• Delayed lymphatic sequelae after duct occlusion

Exam pearls

• TDE requires catheterization; TDD is salvage after failed catheterization.
• The standard antegrade sequence is intranodal mapping, 21 G transabdominal puncture, 0.018-inch wire, 2.4–3 Fr microcatheter, ductography, coils and NBCA.
• For a traumatic leak, embolize upstream in lymphatic flow: caudal to the leak.
• Traumatic and postoperative leaks respond better than nontraumatic effusions; always interpret the lymphangiographic flow pattern before occluding the main duct.
• An early sustained decrease in drain output is the practical marker of clinical response; technical occlusion alone is insufficient.
• Major dangers are visceral or biliary injury, hemorrhage and non-target venous or pulmonary embolization.

Viva questions

What is the difference between thoracic duct embolization and thoracic duct disruption?

TDE requires catheterization of the thoracic duct or causative channel followed by controlled occlusion, usually with coils and NBCA. TDD is a salvage technique after failed cannulation and uses repeated needle puncture of the cisterna chyli or major retroperitoneal lymphatics to interrupt flow.

Why are coils used before glue in conventional TDE?

Coils provide a scaffold, slow lymph flow and reduce the risk of cranial glue migration. Glue then occludes the duct and small tributaries that coils alone may not seal.

Where should the duct be embolized relative to a traumatic leak?

The target duct is occluded upstream in the direction of lymph flow, which means **caudal to the leak**. The embolic construct should cover relevant collateral inflow without reaching the venous termination.

What is the usual access set for antegrade TDE?

A long **21 G** Chiba-type needle is used to puncture the cisterna chyli or lumbar lymphatic, followed by a **0.018-inch** wire and a **2.4–3 Fr** microcatheter.

Why can TDE fail in nontraumatic chylothorax?

Nontraumatic effusion may result from duct obstruction, diffuse lymphatic disease or abnormal reflux rather than a single focal leak. A normal-appearing duct or untargeted flow disorder therefore predicts poorer response to indiscriminate duct occlusion.

What are the important delayed complications of thoracic duct occlusion?

Chronic diarrhea, lower-extremity edema and abdominal swelling or chylous ascites have been reported. The evidence is retrospective and causality is not certain, but these outcomes should be discussed during consent.

References